Unidentified Company Representative
Analyst
Shall we take one question from there and one more from here you’ve been waiting, kindly and I think have – this is it.
John Karidis – Oriel Securities: Yeah, a few questions. Starting from slide 17, you basically pointed out that perhaps your cash flow was 9 year before, 8 this year and now you’re guiding 7 for next year. So if you can share with us, one – if and one cash can stabilize, taken and accounted to different drivers over our smallest dividend and your control operations. Second it’s for Philipp, it’s basically to gain a bit of insight about your margins, making this wholesale agreements, back on the envelope exercise, you’re basically your cost almost double from (inaudible) €10 to almost around €20 - €19, €20, there is still sort of agreements you strike with Deutsche. Meanwhile, the cable keeps close, a pretty good capital pricing in terms of the retail, where a 50 max lines, already retail €26. Now you do well, basically as you pointed out at wholesale, a strong wholesale should come with a strong framework on price squeeze. But the problem is that, there is not a price squeeze, wholesale agreement or (inaudible) on the cables, because the cables are not swapped at regulations. So if you strike and also bring it to an incumbent, meanwhile the pricing on the retail market is being pressurized for the cables, are you not running a risk of actually you basically have lost 19 on this wholesale agreements. And the third, it’s on spectrum, actually it’s a point out from my previous one and I basically cover that – you talk about only the new spectrum when you talk about £100 million projected for investments. Now there is a big elephant in the room, the U.K. renewal, it’s specially coming up pretty soon. Then you will be actually attached in Germany Eagle is coming also. So my suggestion is that it’s pretty difficult to just tell a number, but we have to budget 100 million source of product or in the billions in terms of investment to new spectrum in Europe. Thanks.